Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Malignant Lymphoma

  Free Subscription


Articles published in Bone Marrow Transplant

Retrieve available abstracts of 92 articles:
HTML format



Single Articles


    May 2020
  1. SELLNER L, Schetelig J, Koster L, Choi G, et al
    Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey.
    Bone Marrow Transplant. 2020 May 22. pii: 10.1038/s41409-020-0946.
    PubMed    


  2. SUREDA A, Genadieva Stavrik S, Boumendil A, Finel H, et al
    Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT.
    Bone Marrow Transplant. 2020 May 15. pii: 10.1038/s41409-020-0929.
    PubMed     Abstract available


  3. LIN RJ, Ho C, Devlin SM, Ruiz JD, et al
    Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma.
    Bone Marrow Transplant. 2020 May 13. pii: 10.1038/s41409-020-0942.
    PubMed    


  4. DAMLAJ M, Abuelgasim KA, Alhejazi A, Alahmari B, et al
    Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma.
    Bone Marrow Transplant. 2020 May 13. pii: 10.1038/s41409-020-0935.
    PubMed    


  5. ONISHI A, Inamoto Y, Tajima K, Yamaguchi J, et al
    Detrimental effects of pretransplant cisplatin-based chemotherapy on renal function after allogeneic hematopoietic cell transplantation for lymphoma.
    Bone Marrow Transplant. 2020 May 4. pii: 10.1038/s41409-020-0917.
    PubMed    


    April 2020
  6. DI RENZO N, Musso M, Scime R, Cupri A, et al
    Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin's lymphoma undergoing autologous hematopoietic stem cell transplantat
    Bone Marrow Transplant. 2020 Apr 28. pii: 10.1038/s41409-020-0909.
    PubMed     Abstract available


  7. MOHTY M, Dulery R, Gauthier J, Malard F, et al
    CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview.
    Bone Marrow Transplant. 2020 Apr 18. pii: 10.1038/s41409-020-0892.
    PubMed     Abstract available


  8. JO JC, Kim JS, Lee JH, Lee JH, et al
    Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL).
    Bone Marrow Transplant. 2020 Apr 17. pii: 10.1038/s41409-020-0908.
    PubMed    


  9. TALLEUR AC, Flerlage JE, Shook DR, Chilsen AM, et al
    Autologous hematopoietic cell transplantation for the treatment of relapsed/refractory pediatric, adolescent, and young adult Hodgkin lymphoma: a single institutional experience.
    Bone Marrow Transplant. 2020 Apr 9. pii: 10.1038/s41409-020-0879.
    PubMed     Abstract available


    March 2020
  10. BASTOS-OREIRO M, Balsalobre P, Miralles P, Berenguer J, et al
    Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphoma.
    Bone Marrow Transplant. 2020 Mar 4. pii: 10.1038/s41409-020-0846.
    PubMed     Abstract available


    January 2020
  11. OTHMAN J, Armytage T, Wong K, Arthur C, et al
    Intensive chemotherapy and up-front stem cell transplant for double hit lymphoma.
    Bone Marrow Transplant. 2020 Jan 20. pii: 10.1038/s41409-020-0789.
    PubMed    


  12. HUESO T, Gastinne T, Garciaz S, Tchernonog E, et al
    Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers.
    Bone Marrow Transplant. 2020 Jan 17. pii: 10.1038/s41409-020-0783.
    PubMed     Abstract available


    November 2019
  13. MUSSETTI A, Sureda A
    Is this real life? Is this just fantasy? Decreased relapse following haploidentical transplant in Hodgkin's lymphoma with posttransplant cyclophosphamide.
    Bone Marrow Transplant. 2019 Nov 21. pii: 10.1038/s41409-019-0754.
    PubMed    


  14. BERSVENDSEN HS, Haugnes HS, Dahl AA, Fagerli UM, et al
    Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation.
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0745.
    PubMed     Abstract available


  15. DOMINGO-DOMENECH E, Boumendil A, Climent F, Sengeloev H, et al
    Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT.
    Bone Marrow Transplant. 2019 Nov 6. pii: 10.1038/s41409-019-0734.
    PubMed     Abstract available


  16. DOMINGO-DOMENECH E, Boumendil A, Climent F, Socie G, et al
    Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2019 Nov 6. pii: 10.1038/s41409-019-0732.
    PubMed     Abstract available


    October 2019
  17. ATOUI A, El Labban M, Ghaoui N, El Darsa H, et al
    Correction: Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2019 Oct 4. pii: 10.1038/s41409-019-0706.
    PubMed     Abstract available


    September 2019
  18. SUREDA A, Chabannon C, Masszi T, Pohlreich D, et al
    Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor.
    Bone Marrow Transplant. 2019 Sep 30. pii: 10.1038/s41409-019-0693.
    PubMed     Abstract available


  19. GONZALEZ-BARCA E, Boumendil A, Blaise D, Trneny M, et al
    Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantati
    Bone Marrow Transplant. 2019 Sep 20. pii: 10.1038/s41409-019-0650.
    PubMed     Abstract available


    August 2019
  20. HERR MM, Torka P, Zhang Y, Wallace PK, et al
    Correction: Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant.
    Bone Marrow Transplant. 2019 Aug 30. pii: 10.1038/s41409-019-0647.
    PubMed     Abstract available


  21. HILL BT, Roberts ZJ, Xue A, Rossi JM, et al
    Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma.
    Bone Marrow Transplant. 2019 Aug 30. pii: 10.1038/s41409-019-0657.
    PubMed    


  22. RIVAS MM, Berro M, Prates MV, Yantorno S, et al
    Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment.
    Bone Marrow Transplant. 2019 Aug 21. pii: 10.1038/s41409-019-0640.
    PubMed     Abstract available


  23. ATOUI A, El Labban M, Ghaoui N, El Darsa H, et al
    Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2019 Aug 12. pii: 10.1038/s41409-019-0635.
    PubMed    


  24. EINSELE H, Rasche L, Topp MS, Martin Kortum K, et al
    The use of bispecific antibodies to optimize the outcome of patients with acute leukemia, lymphoma and multiple myeloma after SCT.
    Bone Marrow Transplant. 2019;54.
    PubMed     Abstract available


    June 2019
  25. VISANI G, Loscocco F, Bagaloni I, Ruzzo A, et al
    XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT.
    Bone Marrow Transplant. 2019 Jun 23. pii: 10.1038/s41409-019-0572.
    PubMed    


  26. HERR MM, Torka P, Zhang Y, Wallace PK, et al
    Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant.
    Bone Marrow Transplant. 2019 Jun 21. pii: 10.1038/s41409-019-0591.
    PubMed     Abstract available


    May 2019
  27. DIETRICH S, Dreger P, Hermine O, Kyriakou C, et al
    Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0583.
    PubMed     Abstract available


    April 2019
  28. JAIMOVICH G, Ostriz MBR, Castro M, Riera L, et al
    CBeV (cyclophosphamide, bendamustine and etoposide) pre-autotransplant conditioning in persons with lymphoma.
    Bone Marrow Transplant. 2019 Apr 23. pii: 10.1038/s41409-019-0528.
    PubMed    


    March 2019
  29. PREDILETTO I, Farag SA, Bacher U, Jeker B, et al
    High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients.
    Bone Marrow Transplant. 2019 Mar 19. pii: 10.1038/s41409-019-0508.
    PubMed    


  30. HOLDERRIED TAW, Fraccaroli A, Schumacher M, Heine A, et al
    The role of checkpoint blockade after allogeneic stem cell transplantation in diseases other than Hodgkin's Lymphoma.
    Bone Marrow Transplant. 2019 Mar 4. pii: 10.1038/s41409-019-0498.
    PubMed     Abstract available


    February 2019
  31. KAZUMA Y, Shimazu Y, Hishizawa M, Nishikori M, et al
    Effectiveness of cord blood transplantation for the treatment of refractory angioimmunoblastic T-cell lymphoma: a series of three cases.
    Bone Marrow Transplant. 2019 Feb 26. pii: 10.1038/s41409-019-0494.
    PubMed    


  32. KATO K, Mori T, Kim SW, Sawa M, et al
    Outcome of patients receiving consolidative autologous peripheral blood stem cell transplantation in the frontline treatment of intravascular large B-cell lymphoma: Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantati
    Bone Marrow Transplant. 2019 Feb 26. pii: 10.1038/s41409-019-0491.
    PubMed    


  33. HUBEL K, Re A, Boumendil A, Finel H, et al
    Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party.
    Bone Marrow Transplant. 2019 Feb 25. pii: 10.1038/s41409-019-0480.
    PubMed     Abstract available


    January 2019
  34. ABUELGASIM KA, Alzahrani M, Alsharhan Y, Khairi M, et al
    Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma.
    Bone Marrow Transplant. 2019 Jan 30. pii: 10.1038/s41409-019-0454.
    PubMed    


  35. FUJI S, Yamaguchi T, Inoue Y, Utsunomiya A, et al
    VCAP-AMP-VECP as a preferable induction chemotherapy in transplant-eligible patients with aggressive adult T-cell leukemia-lymphoma: a propensity score analysis.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0446.
    PubMed     Abstract available


    December 2018
  36. JIN A, Feng J, Wang Z, Jiang L, et al
    Severe dyspnea caused by rapid enlargement of cervical lymph node in a relapsed/refractory B-cell lymphoma patient following chimeric antigen receptor T-cell therapy.
    Bone Marrow Transplant. 2018 Dec 18. pii: 10.1038/s41409-018-0412.
    PubMed     Abstract available


  37. YOSHIMITSU M, Utsunomiya A, Fuji S, Fujiwara H, et al
    A retrospective analysis of haplo-identical HLA-mismatch hematopoietic transplantation without posttransplantation cyclophosphamide for GVHD prophylaxis in patients with adult T-cell leukemia-lymphoma.
    Bone Marrow Transplant. 2018 Dec 13. pii: 10.1038/s41409-018-0400.
    PubMed     Abstract available


    November 2018
  38. WULF G, Hasenkamp J, Jung W, Wilhelm C, et al
    Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease.
    Bone Marrow Transplant. 2018 Nov 9. pii: 10.1038/s41409-018-0360.
    PubMed     Abstract available


  39. SAKELLARI I, Gavriilaki E, Bouziana S, Constantinou V, et al
    BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma.
    Bone Marrow Transplant. 2018 Nov 8. pii: 10.1038/s41409-018-0395.
    PubMed    


  40. NORMAN JE, Schouten HC, Dreger P, Robinson SP, et al
    The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies.
    Bone Marrow Transplant. 2018 Nov 2. pii: 10.1038/s41409-018-0372.
    PubMed     Abstract available


  41. DAHI PB, Lazarus HM, Sauter CS, Giralt SA, et al
    Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma.
    Bone Marrow Transplant. 2018 Nov 2. pii: 10.1038/s41409-018-0378.
    PubMed     Abstract available


    October 2018
  42. DOS SANTOS KB, Costa LJM, Bettarello G, da Matta Abreu M, et al
    LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma.
    Bone Marrow Transplant. 2018 Oct 3. pii: 10.1038/s41409-018-0349.
    PubMed    


    August 2018
  43. TSANG ES, Villa D, Loscocco F, Visani G, et al
    High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 31. pii: 10.1038/s41409-018-0328.
    PubMed    


  44. KUNO M, Ito A, Tanaka T, Inamoto Y, et al
    Severe immune-related complications early after allogeneic hematopoietic cell transplantation for nivolumab-pretreated lymphoma.
    Bone Marrow Transplant. 2018 Aug 21. pii: 10.1038/s41409-018-0310.
    PubMed    


  45. PICCALUGA PP, Rapezzi D, Gazzola A, Malagola M, et al
    Resolving the diagnostic dilemma of T-cell clonal expansion after hematopoietic stem cell transplantation in T-cell lymphoma patients by TCR-gamma next generation sequencing.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0268.
    PubMed    


  46. PHILLIPS EH, Lannon MM, Lopes A, Chadwick H, et al
    High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.
    Bone Marrow Transplant. 2018 Aug 13. pii: 10.1038/s41409-018-0294.
    PubMed    


    July 2018
  47. HIRANO M, Jimbo K, Ogawa M, Ochi K, et al
    Chronic inflammatory demyelinating polyneuropathy in adult T-cell leukemia-lymphoma patients following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0202.
    PubMed    


    June 2018
  48. FUJI S, Inoue Y, Utsunomiya A, Moriuchi Y, et al
    Impact of pretransplant central nervous system invasion in patients with aggressive adult T-cell leukemia lymphoma.
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0248.
    PubMed    


  49. KURUVILLA J, Tzeng CH, Cho SG, Kim SJ, et al
    A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin's lymphoma weighing </=70 kg.
    Bone Marrow Transplant. 2018 Jun 12. pii: 10.1038/s41409-018-0253.
    PubMed     Abstract available


  50. BEKADJA MA, Talhi S, Amani K, Osmani S, et al
    Outcomes of modified-eam conditioned autologous non-cryopreserved hematopoietic sct for lymphoma. A retrospective single-centre study.
    Bone Marrow Transplant. 2018 Jun 12. pii: 10.1038/s41409-018-0243.
    PubMed    


  51. ROBINSON SP, Boumendil A, Finel H, Dreger P, et al
    High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: no differences in toxicity or outcome. A matched-control study of the EBMT-Lymphoma Working Party.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0196.
    PubMed     Abstract available


    May 2018
  52. AVIGDOR A, Shouval R, Jacoby E, Davidson T, et al
    CAR T cells induce a complete response in refractory Burkitt Lymphoma.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0235.
    PubMed    


  53. FUJI S, Kurosawa S, Inamoto Y, Murata T, et al
    Decision analysis of up-front autologous hematopoietic stem cell transplantation in patients with peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0223.
    PubMed    


  54. HUBEL K, Ostermann H, Glass B, Noppeney R, et al
    Plerixafor in non-Hodgkin's lymphoma patients: a German analysis of time, effort and costs.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0228.
    PubMed     Abstract available


  55. SUREDA A, Dreger P, Bishop MR, Kroger N, et al
    Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0214.
    PubMed     Abstract available


  56. DREGER P, Michallet M, Bosman P, Dietrich S, et al
    Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0207.
    PubMed     Abstract available


    April 2018
  57. YANG L, Tan Y, Shi J, Zhao Y, et al
    Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma.
    Bone Marrow Transplant. 2018 Apr 30. pii: 10.1038/s41409-018-0184.
    PubMed    


  58. BROWNBACK KR, Pitts LR, Abhyankar S
    Safety of nintedanib for treatment of fibrotic lung disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 26. pii: 10.1038/s41409-018-0182.
    PubMed    


    March 2018
  59. NAITHANI R, Dayal N, Pathak S, Rai R, et al
    Hematopoietic stem cell transplantation using non-cryopreserved peripheral blood stem cells graft is effective in multiple myeloma and lymphoma.
    Bone Marrow Transplant. 2018 Mar 29. pii: 10.1038/s41409-018-0174.
    PubMed    


  60. INOUE Y, Fuji S, Tanosaki R, Inamoto Y, et al
    Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma.
    Bone Marrow Transplant. 2018 Mar 9. pii: 10.1038/s41409-018-0139.
    PubMed     Abstract available


    February 2018
  61. AVIVI I, Boumendil A, Finel H, Nagler A, et al
    Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2018 Feb 20. pii: 10.1038/s41409-017-0063.
    PubMed     Abstract available


  62. MARCHESI F, Capria S, Giannarelli D, Trisolini SM, et al
    BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant.
    Bone Marrow Transplant. 2018 Feb 13. pii: 10.1038/s41409-018-0120.
    PubMed    


  63. HSU YT, Tsai HJ, Chang JS, Li SS, et al
    Stem cell transplantation for T-cell lymphomas in Taiwan.
    Bone Marrow Transplant. 2018 Feb 12. pii: 10.1038/s41409-018-0116.
    PubMed     Abstract available


  64. CASTAGNA L, Boubdallah R, Furst S, Coso D, et al
    Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT.
    Bone Marrow Transplant. 2018;53:234.
    PubMed     Abstract available


    January 2018
  65. FUJI S, Kurosawa S, Inamoto Y, Murata T, et al
    Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-017-0082.
    PubMed    


  66. JIMENEZ-UBIETO A, Grande C, Caballero D, Yanez L, et al
    Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry.
    Bone Marrow Transplant. 2018 Jan 23. pii: 10.1038/s41409-018-0096.
    PubMed    


  67. LAHOUD OB, Moskowitz AJ, Horwitz SM, Giralt SA, et al
    Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma.
    Bone Marrow Transplant. 2018 Jan 22. pii: 10.1038/s41409-017-0086.
    PubMed    


  68. ROBINSON SP, Boumendil A, Finel H, Peggs KS, et al
    Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0067.
    PubMed     Abstract available


  69. GAUTHIER J, Poire X, Gac AC, Leclerc M, et al
    Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0018.
    PubMed     Abstract available


    December 2017
  70. FALCONE U, Jiang H, Bashir S, Tsang R, et al
    Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0054.
    PubMed    


  71. MARIOTTI J, Bramanti S, Devillier R, Furst S, et al
    Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0032.
    PubMed    


  72. MOHTY M, Azar N, Chabannon C, Le Gouill S, et al
    Plerixafor in poor mobilizers with non-Hodgkin's lymphoma: a multi-center time-motion analysis.
    Bone Marrow Transplant. 2017 Dec 18. pii: 10.1038/s41409-017-0033.
    PubMed     Abstract available


    October 2017
  73. JOFFE E, Rosenberg D, Rozovski U, Perry C, et al
    Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin's and non-Hodgkin's B-cell lymphoma.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  74. KANSAGRA A, Inwards DJ, Ansell SM, Micallef IN, et al
    Infusion of autograft natural killer cell/CD14+HLA-DRDIM cell ratio predicts survival in lymphoma post autologous stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  75. RE A, Gini G, Rupolo M, Levis A, et al
    Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed    


  76. GALIENI P, Troiani E, Bigazzi C, Mazzotta S, et al
    Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    PubMed    


  77. RIEDELL PA, Bishop MR
    Post-autologous transplant maintenance therapies in lymphoma: current state and future directions.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


    August 2017
  78. FREEMAN AT, Stover AM, Grover NS, Shea TC, et al
    Patient perspectives on physical function after allogeneic hematopoietic stem cell transplantation: a qualitative study.
    Bone Marrow Transplant. 2017 Aug 7. doi: 10.1038/bmt.2017.
    PubMed    


    July 2017
  79. DAMLAJ M, Ghazi S, Syed G, Pasha T, et al
    Pre-autologous transplantation PET/CT using Deauville criteria is an independent predictor of progression in relapsed refractory classical Hodgkin lymphoma.
    Bone Marrow Transplant. 2017 Jul 10. doi: 10.1038/bmt.2017.
    PubMed    


    June 2017
  80. KASSAM S, Chernucha E, O'Neill A, Hemmaway C, et al
    High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom.
    Bone Marrow Transplant. 2017 Jun 5. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  81. GIACCONE L, Festuccia M, Zallio F, Sorasio R, et al
    Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma.
    Bone Marrow Transplant. 2017 Jun 5. doi: 10.1038/bmt.2017.
    PubMed    


    May 2017
  82. BENTO L, Boumendil A, Finel H, Le Gouill S, et al
    Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.
    Bone Marrow Transplant. 2017 May 22. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  83. CASTAGNA L, Bramanti S, Devillier R, Sarina B, et al
    Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma.
    Bone Marrow Transplant. 2017;52:797.
    PubMed    


    April 2017
  84. SCHORB E, Fox CP, Fritsch K, Isbell L, et al
    High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study.
    Bone Marrow Transplant. 2017 Apr 24. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  85. EL CHEIKH J, Massoud R, Abudalle I, Haffar B, et al
    Nivolumab salvage therapy before or after allogeneic stem cell transplantation in Hodgkin lymphoma.
    Bone Marrow Transplant. 2017 Apr 10. doi: 10.1038/bmt.2017.
    PubMed    


  86. YAMASAKI S, Suzuki R, Hatano K, Fukushima K, et al
    Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma.
    Bone Marrow Transplant. 2017 Apr 3. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  87. GARNIER A, Guillaume T, Peterlin P, Bene MC, et al
    Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier.
    Bone Marrow Transplant. 2017 Apr 3. doi: 10.1038/bmt.2017.
    PubMed    


    February 2017
  88. BOURLON C, Alamoudi S, Kumar D, Viswabandya A, et al
    A short tale of blood, kidney and brain: BK virus encephalitis in an allogeneic stem cell transplant recipient.
    Bone Marrow Transplant. 2017 Feb 20. doi: 10.1038/bmt.2017.
    PubMed    


    January 2017
  89. MCDUFFEE E, Aue G, Cook L, Ramos-Delgado C, et al
    Tumor regression concomitant with steroid-refractory GvHD highlights the pitfalls of PD-1 blockade following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed    


    October 2016
  90. GAUTHIER J, Holmberg L, Wu D, Bensinger W, et al
    Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas.
    Bone Marrow Transplant. 2016 Oct 24. doi: 10.1038/bmt.2016.
    PubMed    


    September 2016
  91. BAI L, Peters L, Xia W, Best G, et al
    Assessing pilot vial material as a surrogate for functional and phenotypic stem cell markers in cryopreserved haematopoietic stem cell product.
    Bone Marrow Transplant. 2016 Sep 26. doi: 10.1038/bmt.2016.
    PubMed    


    July 2016
  92. EHRLICH KB, Miller GE, Scheide T, Baveja S, et al
    Pre-transplant emotional support is associated with longer survival after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Jul 18. doi: 10.1038/bmt.2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: